Hodgkin's disease following Wilms' tumor: a case report.
A patient is described who developed Hodgkin's disease 16 years after treatment of Wilms' tumor with radiation and actinomycin D. The issues relating to Hodgkin's disease as a second malignancy are reviewed. The need for long-term surveillance of patients with malignant disease for late effects of the cancer and its treatment is emphasized.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008466:Mechlorethamine / Q000008:administration & dosage; D009378:Neoplasms, Multiple Primary / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage; D009396:Wilms Tumor / Q000473:pathology* / Q000628:therapy
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone